Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study
2007

EGFR Gene Variants and Lung Cancer Risk

Sample size: 1164 publication Evidence: moderate

Author Information

Author(s): Choi Jin Eun, Ha Park Sun, Kim Kyung Mee, Lee Won Kee, Kam Sin, Cha Sung Ick, Ho Kim Chang, Mo Kang Young, Kim Young-Chul, Han Sung Beom, Jung Tae Hoon, Park Jae Yong

Primary Institution: Kyungpook National University

Hypothesis

Polymorphisms in the epidermal growth factor receptor (EGFR) gene may influence susceptibility to lung cancer.

Conclusion

The EGFR polymorphisms, particularly the 181946C>T polymorphism, could be used as markers for genetic susceptibility to lung cancer.

Supporting Evidence

  • The 181946C>T genotype was associated with a significantly decreased risk of lung cancer.
  • The protective effect of the TT genotype was statistically significant in ever-smokers.
  • The CGGCT haplotype with the 181946C allele was associated with a significantly increased risk of lung cancer.

Takeaway

Some changes in a gene called EGFR might make people more likely to get lung cancer, especially if they smoke.

Methodology

A case-control study was conducted with 582 lung cancer patients and 582 healthy controls, examining specific polymorphisms in the EGFR gene.

Limitations

The study may have type I and type II errors due to multiple comparisons and small subgroup sizes.

Participant Demographics

Participants included 582 lung cancer patients and 582 healthy controls, all ethnic Koreans from Daegu City.

Statistical Information

P-Value

0.007

Confidence Interval

95% CI = 0.45–0.88

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-199

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication